Vestal Point Capital »

Bristol Myers Squibb shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Bristol Myers Squibb (BMY) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Bristol Myers Squibb

Tip: Access up to 7 years of quarterly data

All positions including Bristol Myers Squibb held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bristol Myers Squibb by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $21M 500k 41.53

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Bristol Myers Squibb

Vanguard Group
BlackRock
State Street Corporation
Jpmorgan Chase & Co
Capital Research and Management Company - Division 3
Charles Schwab Investment Management
FMR
Geode Capital Management
Morgan Stanley
Citadel Advisors
PRIMECAP Management Company
Northern Trust
Susquehanna International
Ameriprise Financial
Legal & General Group

View all funds holding Bristol Myers Squibb